Bryan, Garnier & Co leads a €8m private placement for Orège

Bryan, Garnier & Co leads a €8m private placement for Orège

News published on July Wednesday 6, 2011
Share on

Paris, July 6th 2011 - Bryan, Garnier & Co, the independent pan-European Investment Bank for growth companies, announces the completion of a € 8.0m capital increase for Orège, a wastewater treatment solution provider.

The capital increase has been funded by Climate Change Capital (CPE), with €6m of the €8m round, alongside with Oraxys SA, a Luxembourg-based cleantech private equity fund.

Orège has 40 employees and is based in Jouy-en-Josas, near Paris, and has an R&D facility in Aix-en-Provence. Orège plans to achieve €5.0m turnover this year. Orège has now filed four patents relating to its two key technologies:

SOFHYS® technology for the treatment of industrial effluents contaminated with hydrocarbons.

SLG technology for the de-watering and the treatment of industrial sludge.

Orège’s patents are advanced wastewater treatment solutions in a highly cost efficient manner. The resulting water from the treatment process can be reused for industrial purposes or released back into the natural environment.

Orège’s management appointed Bryan, Garnier & Co with the objective of raising funds from leading international investors. Among numerous specialized investors Climate Change Capital and Oraxys’ were selected based on their in-depth knowledge of the wastewater market and their ability to access a broad range of potential new clients for Orège.

Pascal Gendrot, Orège’s Chief Executive Officer said: “Orège is delighted to welcome blue-chip international investors CPE and Oraxys among its shareholders. This is a key milestone in Orège’s development: we have substantial capital to build on our commercial successes and to accelerate the expansion of Orège in France and internationally through investments into our own fleet of mobile SOFHYS® and SLG units. Our new investors also bring us key industrial connections to support our growth in France and internationally.”

François Arpels, Managing Director at Bryan, Garnier & Co, added that:” This transaction demonstrates Bryan Garnier's ability to generate interest internationally and as a result to secure attractive deals for its clients. We are proud to bring our clients our global network and our local expertise."

“This is another key transaction for Bryan Garnier’s Cleantech franchise. Our ongoing investments across our investment banking platform in the renewable space continue to bear fruit: after transactions in sectors such as Solar, Wind, Biomass, Biogaz and Carbon Credit markets across broad geographies including Italy, the United Kingdom, Sweden and France, we further expand our footprint and expertise in the sector with this transaction in the fast growing Water Technology industry. While many premier water technology franchises are bottled inside large multi-industry global companies, Orege is one of the few independent players with ground breaking technology which has the potential to redefine processes in its field of expertise” states Olivier Beaudouin, Managing Director leading the cleantech franchise effort at Bryan, Garnier & Co.

Bryan, Garnier & Co acted as exclusive financial adviser to Orège.

For more information, please contact:

About Orège:

Orège SA is an integrated wastewater treatment solution provider. Its customer offering include definition and tuning of the treatment protocol, industrial design of the processing line, integrated design office capability, project management with high value-added with subcontractors and local regulatory bodies. Orège’s offering is focused primarily on industrial firms in the oil & gas, mining, petrochemical and chemical industries.

Recent Transactions

  • July 2011 IPO of LeadMedia Group (ALLMG)
  • June 2011 Sale of Jobpartners to Taleo Corp (TLEO)
  • June 2011: Secondary LBO of Irium by Initiative & Finance
  • June 2011: Sale of Sword Insurance to leading private equity firm Thomas H. Lee Partners
  • May 2011: Sale of Telemarket to Systeme U
  • May 2011: Disposal of Sword Fircosoft to R Capital Management
  • May 2011: Sale of Modelabs (MDL) to Bigben Interactive (BIG) (pending)
  • May 2011: Acquisition of AES Chemunex by BioMerieux (pending)
  • May 2011: IPO of Concoursmania (ALGCM)
  • April 2011: Public to Private of Metrologic (MGT) led by the Carlyle Group (62% controling block followed by tender offer)
  • April 2011: Buy out of DCI by its Management

About Bryan, Garnier & Co

Bryan, Garnier & Co is an independent investment bank specialising in European TMT, Healthcare and Renewable Energies growth companies. Bryan, Garnier & Co is positioned in three activities: Equity Research & Brokerage, Asset Management and Corporate Finance.

With more than 120 professionals based in London, Paris, New York and Geneva, Bryan, Garnier & Co combines the range of services and the expertise of top-tier investment banks with the level of attention to clients of a boutique.

Through its corporate finance practice, Bryan, Garnier & Co has became a leader in advising European growth companies on strategic finance transactions such as mergers & acquisitions, equity capital market, LBOs and private placement over the last three years.

Bryan, Garnier & Co is authorized and regulated by the Financial Services Authority (FSA) in the United Kingdom, and is member of London Stock Exchange and Euronext, Alternext Listing Sponsor, and is active on all European capital markets.

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities